Fangda Partners
Firm overview:
Founded in 1993, Fangda Partners is a single partnership, full-service law firm advising on PRC and Hong Kong laws. The firm has 800 lawyers in six offices in Beijing, Guangzhou, Hong Kong, Nanjing, Shanghai and Shenzhen.
Fangda has achieved a number of notable legislative precedents in China. The corporate practice advised on the first foreign acquisition of a controlling stake in a Chinese public company. The IP practice represented the claimant in obtaining the first injunction in an IP litigation under Chinese procedural law and the patents practice advised on the first FRAND litigation in China.
Fangda has well-recognized expertise in intellectual property. We have successfully litigated many groundbreaking cases and have also advised on many of China’s leading transactions. We are the preferred choice of clients in many industries on patent, trademark, copyright, trade secrets and IP-related antitrust law matters.
With an appellate litigation and advocacy patents practice, Fangda has successfully argued cases before provincial high courts and the PRC Supreme Court. The firm has also advised on domestic and cross-border transactions involving procurement, acquisition, assignment or licence in technology, brands, patents, copyrights and other forms of IP.
These transactions include franchising, licensing, distribution, outsourcing, contract manufacturing, joint ventures, mergers & acquisitions, strategic alliances and technology research and development.
Team overview:
Fangda has lawyers qualified in Australia, England and Wales, Singapore, the US, Hong Kong and the PRC.
The patent team have technical backgrounds in multiple fields, alongside former judges and patent examiners.
Key matters:
- Fangda assisted Huizhou Huahong New Materials in a Supreme People's Court’s final judgment (Judicial Review No. (2021) SPC Intellectual Property Zhi Xing Zhong No. 1172) in a patent case related to a photo-curable composition used for solvent curing that is particularly suitable for food and cosmetics external package printing.
- The Supreme Court decision reversed the trial court judgments of the China National Intellectual Property Administration's decision on invalidation request examination (No. 44388) and the first-instance judgment by the Beijing Intellectual Property Court (Case No. (2020) Beijing 73 Administrative Xing Chu No. 12112).
- The Fangda team represented Huahong New Material in the second-instance litigation and successfully secured an overturning final judgment by the SPC, prompting the CNIPA to reevaluate the contested patent.
- The Fangda team was led by partner Zou Wen, with associate Xie Xiaoxiong.
Clients:
Patent Litigation/Invalidation: Huizhou Huahong New Materials, Valeo, L’Oréal, Nordson Corporation, Watson Pharmaceuticals, Nordson Corporation, Sucampo Pharmaceuticals, Knowles Corporation; FRAND: InterDigital, The9, Towana
